Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma

被引:0
|
作者
Rebecca L. King
Eric D. Hsi
Wing C. Chan
Miguel A. Piris
James R. Cook
David W. Scott
Steven H. Swerdlow
机构
[1] Mayo Clinic,Division of Hematopathology
[2] Wake Forest School of Medicine,Department of Laboratory Medicine
[3] City of Hope National Medical Center,Department of Pathology
[4] Jiménez Díaz Foundation University Hospital,Department of Pathology
[5] Cleveland Clinic,Pathology and Laboratory Medicine Institute
[6] BC Cancer,Centre for Lymphoid Cancer
[7] University of Pittsburgh School of Medicine,Department of Pathology
来源
Virchows Archiv | 2023年 / 482卷
关键词
High-grade B-cell lymphoma; Burkitt; Diffuse large B-cell lymphoma; International Consensus Classification;
D O I
暂无
中图分类号
学科分类号
摘要
Since the 2016 WHO update, progress has been made in understanding the biology of Burkitt lymphoma (BL) and the concept of high-grade B-cell lymphomas (HGBCL) that allows some degree of refinement. The summary presented here reviews in detail the discussions of the Clinical Advisory Committee and expands upon the newly published 2022 International Consensus Classification for lymphoid malignancies (Campo et al. Blood, 2022). BL remains the prototypic HGBCL and diagnostic criteria are largely unchanged. HGBCL with MYC and BCL2 and HGBCL with MYC and BCL6 rearrangements are now separated to reflect biologic and pathologic differences. HGBCL, NOS remains a diagnosis of exclusion that should be used only in rare cases. FISH strategies for diffuse large B-cell lymphoma (DLBCL) and HGBCL are discussed in detail for these diseases. Advances in integrative analysis of mutations, structural abnormalities, copy number, and gene expression signatures allow a more nuanced view of the heterogeneity of DLBCL, NOS as well as definitions of HGBCL and point to where the future may be headed for classification of these diseases.
引用
收藏
页码:193 / 205
页数:12
相关论文
共 50 条
  • [1] Diagnostic approaches and future directions in Burkitt lymphoma and high-grade B-cell lymphoma
    King, Rebecca L.
    Hsi, Eric D.
    Chan, Wing C.
    Piris, Miguel A.
    Cook, James R.
    Scott, David W.
    Swerdlow, Steven H.
    VIRCHOWS ARCHIV, 2023, 482 (01) : 193 - 205
  • [2] Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas
    Johnson, P. Connor
    Abramson, Jeremy S.
    ONCOLOGY-NEW YORK, 2022, 36 (08): : 499 - 505
  • [3] Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma
    Lap, Coen J.
    Nassereddine, Samah
    Dunleavy, Kieron
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (07)
  • [4] Novel Biological Insights and New Developments in Management of Burkitt Lymphoma and High-Grade B-Cell Lymphoma
    Coen J. Lap
    Samah Nassereddine
    Kieron Dunleavy
    Current Treatment Options in Oncology, 2021, 22
  • [5] Management of High-Grade B-Cell Lymphoma
    Olszewski, Adam J.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S41 - S43
  • [6] Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Ko, Heidi
    Khoury, Joseph D.
    Ravandi, Farhad
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Khouri, Maria
    Cortes, Jorge E.
    Wierda, William G.
    Verstovsek, Srdan
    Estrov, Zeev
    Ferrajoli, Alessandra
    Thompson, Philip A.
    Pierce, Sherry
    O'Brien, Susan M.
    Jabbour, Elias
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (06) : E114 - E116
  • [7] Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets
    Bouska, Alyssa
    Bi, Chengfeng
    Lone, Waseem
    Zhang, Weiwei
    Kedwaii, Ambreen
    Heavican, Tayla
    Lachel, Cynthia M.
    Yu, Jiayu
    Ferro, Roberto
    Eldorghamy, Nanees
    Greiner, Timothy C.
    Vose, Julie
    Weisenburger, Dennis D.
    Gascoyne, Randy D.
    Rosenwald, Andreas
    Ott, German
    Campo, Elias
    Rimsza, Lisa M.
    Jaffe, Elaine S.
    Braziel, Rita M.
    Siebert, Reiner
    Miles, Rodney R.
    Dave, Sandeep
    Reddy, Anupama
    Delabie, Jan
    Staudt, Louis M.
    Song, Joo Y.
    McKeithan, Timothy W.
    Fu, Kai
    Green, Michael
    Chan, Wing C.
    Iqbal, Javeed
    BLOOD, 2017, 130 (16) : 1819 - 1831
  • [8] Impact of timing and precision of histopathological diagnosis on outcomes of patients with Burkitt lymphoma and high-grade B-cell lymphoma
    Graef, Claus Moritz
    Goedel, Philipp
    Falderbaum, Philipp
    Balke-Want, Hyatt
    Simon, Florian
    Sieg, Noelle
    Naendrup, Jan-Hendrik
    Neumann, Marie Anne-Catherine
    Gillessen, Sarah
    Broeckelmann, Paul J.
    Eichenauer, Dennis A.
    Borchmann, Peter
    von Tresckow, Bastian
    Heger, Jan-Michel
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2022, 108 (05) : 403 - 412
  • [9] High-Grade B-Cell Lymphoma with Features Intermediate between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma (Grey Zone Lymphoma): A Clinicopathologic Analysis of 39 Cases
    Perry, A.
    Dave, B.
    Crockett, D.
    Althof, P.
    Smith, L.
    Aoun, P.
    Chan, W.
    Fu, K.
    Greiner, T.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    Vose, J.
    Weisenburger, D.
    MODERN PATHOLOGY, 2012, 25 : 361A - 361A
  • [10] High-Grade B-Cell Lymphoma with Features Intermediate between Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma (Grey Zone Lymphoma): A Clinicopathologic Analysis of 39 Cases
    Perry, A.
    Dave, B.
    Crockett, D.
    Althof, P.
    Smith, L.
    Aoun, P.
    Chan, W.
    Fu, K.
    Greiner, T.
    Bierman, P.
    Bociek, G.
    Armitage, J.
    Vose, J.
    Weisenburger, D.
    LABORATORY INVESTIGATION, 2012, 92 : 361A - 361A